Influence of dietary supplementation with sunflower oil and quebracho tannins on growth performance and meat fatty acid profile of Awassi lambs

The inclusion of QT in the diet increased the content of the conjugated linoleic acid in the lamb meat above that achieved with SF supplementation only. Addition of the combination of QT and SF to the diet enhanced the content of conjugated linoleic acid (C18:2 c9t11) of the lamb meat. This could be due to the reduction in the bio-hydrogenation of unsaturated fatty acids in the diet. The results suggest that inclusion the combination of QT and SF in lamb diets improved the healthy fatty acids content in the meat without an adverse effect on animal performance.The influence of dietary supplementation with quebracho tannins (QT) or/and sunflower oil (SF) on growth performance and fatty acid profile in meat of Awassi lambs was studied. Seventy-two lambs were assigned randomly to nine diets (8 per group) in the experiment following a 32 factorial design with all possible combinations of two factors, SF and QT each at three levels i.e. 0 (control), 20 or 40 g/kg diet DM. A significant SF ×QT interaction was observed on the conjugated linoleic acid content of intramuscular fat (P =0.007), but not on average daily weight gain (P=0.11). Addition of QT at 40 g/ kg DM significantly increased average daily gain comparing to control diet

A comparative study of high-field diamagnetic fluctuations in deoxygenated YBa2Cu3O(7-x) and polycrystalline (Bi-Pb)2Sr2Ca3O(10)

We studied three single crystals of YBa2Cu3O{7-x} with Tc= 62.5, 52, and 41 K, and a textured specimen of (Bi-Pb)2Sr2Ca2Cu3O10 with Tc=108 K, for H//c axis. The reversible data were interpreted in terms of 2D lowest-Landau-level fluctuation theory. The data were fit well by the 2D LLL expression for magnetization obtained by Tesanovic etal., producing reasonable values of kappa but larger values of dHc2/dT. Universality was studied by obtaining a simultaneous scaling of Y123 data and Bi2223. An expression for the 2D x-axis LLL scaling factor used to obtain the simultaneous scaling was extracted from theory, and compared with the experimental values. The comparison between the values of the x-axis produced a deviation of 40% which suggests that the hypothesis of universality of the 2D-LLL fluctuations is not supported by the studied samples. We finaly observe that Y123 magnetization data for temperatures above $T_c$ obbey a universal scaling obtained for the diamagnetic fluctuation magnetization from a theory considering non-local field effects. The same scaling was not obbeyed by the corresponding magnetization calculated from the two-dimensional lowest-Landau-level theory.Comment: 7 pages 5 figures, accept in Journ. Low Temp. Phy

Arithmetic progressions in sets of fractional dimension

Let E\subset\rr be a closed set of Hausdorff dimension $\alpha$. We prove that if $\alpha$ is sufficiently close to 1, and if $E$ supports a probabilistic measure obeying appropriate dimensionality and Fourier decay conditions, then $E$ contains non-trivial 3-term arithmetic progressions.Comment: 42 page

Carbon Recombination Lines from the Galactic Plane at 34.5 & 328 MHz

We present results of a search for carbon recombination lines in the Galaxy at 34.5 MHz (C$575\alpha$) made using the dipole array at Gauribidanur near Bangalore. Observations made towards 32 directions, led to detections of lines in absorption at nine positions. Followup observations at 328 MHz (C$272\alpha$) using the Ooty Radio Telescope detected these lines in emission. A VLA D-array observation of one of the positions at 330 MHz yielded no detection implying a lower limit of 10' for the angular size of the line forming region. The longitude-velocity distribution of the observed carbon lines indicate that the line forming region are located mainly between 4 kpc and 7 kpc from the Galactic centre. Combining our results with published carbon recombination line data near 76 MHz (\nocite{erickson:95} Erickson \et 1995) we obtain constraints on the physical parameters of the line forming regions. We find that if the angular size of the line forming regions is $\ge 4^{\circ}$, then the range of parameters that fit the data are: \Te $= 20-40$ K, \ne $\sim 0.1-0.3$ \cm3 and pathlengths $\sim 0.07-0.9$ pc which may correspond to thin photo-dissociated regions around molecular clouds. On the other hand, if the line forming regions are $\sim 2^{\circ}$ in extent, then warmer gas (\Te $\sim 60-300$ K) with lower electron densities (\ne $\sim 0.03-0.05$ \cm3) extending over several tens of parsecs along the line of sight and possibly associated with atomic \HI gas can fit the data. Based on the range of derived parameters, we suggest that the carbon line regions are most likely associated with photo-dissociation regions.Comment: To appear in Journal of Astrophysics & Astronomy, March 200

Solar Wind Turbulence and the Role of Ion Instabilities

International audienc

Self-help groups challenge health care systems in the US and UK

Purpose: This research considers how self-help groups (SHGs) and self- help organizations (SHOs) contribute to consumerist trends in two different societies: United States and United Kingdom. How do the health care systems and the voluntary sectors affect the kinds of social changes that SHGs/SHOs make? Methodology/approach: A review of research on the role of SHGs/SHOs in contributing to national health social movements in the UK and US was made. Case studies of the UK and the US compare the characteristics of their health care systems and their voluntary sector. Research reviews of two community level self-help groups in each country describe the kinds of social changes they made. Findings: The research review verified that SHGs/SHOs contribute to national level health social movements for patient consumerism. The case studies showed that community level SHGs/SHOs successfully made the same social changes but on a smaller scale as the national movements, and the health care system affects the kinds of community changes made. Research limitations: A limited number of SHGs/SHOs within only two societies were studied. Additional SHGs/SHOs within a variety of societies need to be studied. Originality/value of chapter Community SHGs/SHOs are often trivialized by social scientists as just inward-oriented support groups, but this chapter shows that local groups contribute to patient consumerism and social changes but in ways that depend on the kind of health care system and societal context

Solar parameters for modeling interplanetary background

The goal of the Fully Online Datacenter of Ultraviolet Emissions (FONDUE) Working Team of the International Space Science Institute in Bern, Switzerland, was to establish a common calibration of various UV and EUV heliospheric observations, both spectroscopic and photometric. Realization of this goal required an up-to-date model of spatial distribution of neutral interstellar hydrogen in the heliosphere, and to that end, a credible model of the radiation pressure and ionization processes was needed. This chapter describes the solar factors shaping the distribution of neutral interstellar H in the heliosphere. Presented are the solar Lyman-alpha flux and the solar Lyman-alpha resonant radiation pressure force acting on neutral H atoms in the heliosphere, solar EUV radiation and the photoionization of heliospheric hydrogen, and their evolution in time and the still hypothetical variation with heliolatitude. Further, solar wind and its evolution with solar activity is presented in the context of the charge exchange ionization of heliospheric hydrogen, and in the context of dynamic pressure variations. Also the electron ionization and its variation with time, heliolatitude, and solar distance is presented. After a review of all of those topics, we present an interim model of solar wind and the other solar factors based on up-to-date in situ and remote sensing observations of solar wind. Results of this effort will further be utilised to improve on the model of solar wind evolution, which will be an invaluable asset in all heliospheric measurements, including, among others, the observations of Energetic Neutral Atoms by the Interstellar Boundary Explorer (IBEX).Comment: Chapter 2 in the planned "Cross-Calibration of Past and Present Far UV Spectra of Solar System Objects and the Heliosphere", ISSI Scientific Report No 12, ed. R.M. Bonnet, E. Quemerais, M. Snow, Springe

Defining the Critical Hurdles in Cancer Immunotherapy

ABSTRACT: Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a scientific basis, others do not. We need to do better. Innovative strategies need to move into early stage clinical trials as quickly as it is safe, and if successful, these therapies should efficiently obtain regulatory approval and widespread clinical application. In late 2009 and 2010 the Society for Immunotherapy of Cancer (SITC), convened an "Immunotherapy Summit" with representatives from immunotherapy organizations representing Europe, Japan, China and North America to discuss collaborations to improve development and delivery of cancer immunotherapy. One of the concepts raised by SITC and defined as critical by all parties was the need to identify hurdles that impede effective translation of cancer immunotherapy. With consensus on these hurdles, international working groups could be developed to make recommendations vetted by the participating organizations. These recommendations could then be considered by regulatory bodies, governmental and private funding agencies, pharmaceutical companies and academic institutions to facilitate changes necessary to accelerate clinical translation of novel immune-based cancer therapies. The critical hurdles identified by representatives of the collaborating organizations, now organized as the World Immunotherapy Council, are presented and discussed in this report. Some of the identified hurdles impede all investigators, others hinder investigators only in certain regions or institutions or are more relevant to specific types of immunotherapy or first-in-humans studies. Each of these hurdles can significantly delay clinical translation of promising advances in immunotherapy yet be overcome to improve outcomes of patients with cancer